ADVANCED MALIGNANT SOLID TUMOR
Clinical trials for ADVANCED MALIGNANT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT SOLID TUMOR trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Modified virus tested as new weapon against tough cancers
Disease control Recruiting nowThis is an early-stage safety study testing a new therapy called VG2062 in people with advanced solid tumors that have stopped responding to standard treatments. VG2062 is a modified virus designed to infect and kill cancer cells. The main goal is to find a safe dose and understa…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: Shanghai Virogin Biotech Co., Ltd. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New cancer drug enters human testing for Tough-to-Treat tumors
Disease control Recruiting nowThis is an early-stage clinical trial testing a new drug called MHB042C in adults with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and see if the drug shows any signs of helping to control the cancer. The study will…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New cancer drug enters human testing for advanced tumors
Disease control Recruiting nowThis is the first study in people to test a new drug called MHB048C for advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and see if the drug shows early signs of helping to control the cancer. The study will enroll about…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New weapon against advanced cancer begins human testing
Disease control Recruiting nowThis is the first-ever study in humans of an experimental antibody called GEN1057 for treating advanced solid tumors. The trial aims to find a safe dose and see early signs of whether the treatment can shrink tumors. It will enroll about 45 adults with metastatic or advanced canc…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: Genmab • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New cancer drug begins human testing
Disease control Recruiting nowThis is the first human study of an experimental cancer drug called PLT012. Researchers want to find the safest dose for adults with advanced solid tumors and see if it shows early signs of helping. All 36 participants will receive the drug through an IV every three weeks while d…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: Pilatus Biosciences Inc • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New cancer drug trial seeks to turn Patient's own immune cells against tumors
Disease control Recruiting nowThis early-stage trial is testing a new drug called RPTR-1-201, which is designed to guide a patient's own immune cells to attack advanced solid tumors. It will enroll about 150 adults to first find a safe dose and then see if the drug can shrink tumors, either alone or combined …
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Repertoire Immune Medicines • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
New Two-Drug attack on advanced cancers enters Mid-Stage testing
Disease control Recruiting nowThis study is testing a combination of two new drugs, MHB036C and MHB039A, for people with advanced breast cancer or other advanced solid tumors that have spread. The main goals are to see if the drug combination is safe, how the body processes it, and if it can shrink or control…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
First human test of experimental cancer drug duo begins
Disease control Recruiting nowThis is an early-stage study testing a new combination of two drugs, MHB088C and MHB039A, for people with advanced solid tumors that have not responded to standard treatments. The main goals are to find the safest dose and see if the drugs show any early signs of fighting the can…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated Mar 09, 2026 14:22 UTC
-
Scientists test if damaged livers change cancer drug effects
Knowledge-focused Recruiting nowThis early study aims to understand how liver problems affect the way the body processes a cancer drug called tazemetostat. It will compare blood levels of the drug in people with advanced cancer who have normal liver function to those with moderate or severe liver impairment. Th…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: Epizyme, Inc. • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC